IN2014DN09410A - - Google Patents
Info
- Publication number
- IN2014DN09410A IN2014DN09410A IN9410DEN2014A IN2014DN09410A IN 2014DN09410 A IN2014DN09410 A IN 2014DN09410A IN 9410DEN2014 A IN9410DEN2014 A IN 9410DEN2014A IN 2014DN09410 A IN2014DN09410 A IN 2014DN09410A
- Authority
- IN
- India
- Prior art keywords
- proteomic profile
- psg
- fibronectin
- expression
- gestational diabetes
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623690P | 2012-04-13 | 2012-04-13 | |
| PCT/US2013/030152 WO2013154709A1 (fr) | 2012-04-13 | 2013-03-11 | Biomarqueurs maternels pour le diabète gestationnel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09410A true IN2014DN09410A (fr) | 2015-07-17 |
Family
ID=49325612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9410DEN2014 IN2014DN09410A (fr) | 2012-04-13 | 2013-03-11 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8852873B2 (fr) |
| EP (1) | EP2836845B1 (fr) |
| CN (1) | CN104380112B (fr) |
| ES (1) | ES2684976T3 (fr) |
| IN (1) | IN2014DN09410A (fr) |
| WO (1) | WO2013154709A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160025737A1 (en) * | 2014-07-25 | 2016-01-28 | Diabetomics, Llc | Biomarkers for assessment of preeclampsia |
| EP3271730B1 (fr) * | 2015-03-20 | 2019-10-09 | IQ Products B.V. | Nouveau marqueur du diabète gestationnel |
| CN106706928A (zh) * | 2017-01-19 | 2017-05-24 | 深圳大学 | 一种妊娠期糖尿病的早期预测标志物及其检测方法 |
| CN107024590A (zh) * | 2017-03-13 | 2017-08-08 | 新疆医科大学 | 一种诊断1型和2型糖尿病的血清蛋白标志物组 |
| CN113514634A (zh) * | 2020-04-09 | 2021-10-19 | 武汉市朗典精医生物科技有限公司 | 制备检测Adipo/SHBG双指标免疫层析试剂盒 |
| CN113804879A (zh) * | 2020-06-15 | 2021-12-17 | 北京康美天鸿生物科技有限公司 | 幽门螺旋杆菌IgM和IgG抗体联合检测试剂盒 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4855242A (en) | 1986-04-14 | 1989-08-08 | Joslin Diabetes Center, Inc. | Method of detecting antibodies |
| DE3800048A1 (de) | 1987-05-14 | 1988-11-24 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten |
| US5645998A (en) | 1988-12-13 | 1997-07-08 | University Of Florida Research Foundation | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| US5175085A (en) | 1990-02-20 | 1992-12-29 | Board Of Regents, The University Of Texas System | Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus |
| AU8721991A (en) | 1990-09-07 | 1992-03-30 | Regents Of The University Of California, The | Methods for the diagnosis and treatment of diabetes |
| US5512447A (en) | 1990-09-07 | 1996-04-30 | The Regents Of The University Of California | Methods for the diagnosis and treatment of diabetes |
| US5674978A (en) | 1990-09-21 | 1997-10-07 | The Regents Of The University Of California | Peptides derived from glutamic acid decarboxylase |
| DE4129849A1 (de) | 1991-02-14 | 1992-08-27 | Boehringer Mannheim Gmbh | Monoklonale antikoerper gegen humane pankreas-inselzellen |
| JPH06508030A (ja) | 1991-05-15 | 1994-09-14 | ザイモジェネティクス，インコーポレイティド | ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現 |
| US5674692A (en) | 1991-09-06 | 1997-10-07 | Baekkeskov; Steinunn | Methods for diabetes susceptibility assessment in asymptomatic patients |
| US5200318A (en) | 1992-05-13 | 1993-04-06 | Miles Inc. | Diagnosis of IDDM with a panel of immunoreagents |
| JP4242446B2 (ja) | 1992-12-03 | 2009-03-25 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 糖尿病及びスティフマン症候群の診断及び治療用改良試薬及び方法 |
| IL108587A (en) | 1993-02-09 | 1998-01-04 | Univ Monash | Methods and kit for diagnosing diabetes and pre-diabetic conditions |
| WO1994024564A1 (fr) | 1993-04-16 | 1994-10-27 | The Regents Of The University Of California | Methodes de determination de la susceptibilite au diabete chez des patients asymptomatiques |
| US5547847A (en) | 1993-09-07 | 1996-08-20 | University Of Washington | Diagnosis of insulin-dependent diabetes |
| US5561049A (en) | 1994-09-21 | 1996-10-01 | Behringwerke Ag | Method for detecting antibodies |
| US6391651B1 (en) | 1995-08-11 | 2002-05-21 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Materials and methods for detection of insulin dependent diabetes |
| US5989551A (en) | 1995-10-25 | 1999-11-23 | The United States Of America As Represented By The Department Of Health And Human Services | Materials and methods for detection and treatment of insulin-dependent diabetes |
| US5821334A (en) | 1996-01-26 | 1998-10-13 | Vanderbilt University | Insulin-dependent diabetes mellitus-specific chimeric polypeptides |
| WO1997032984A1 (fr) | 1996-03-06 | 1997-09-12 | Zymogenetics, Inc. | PROTEINE-TYROSINE PHOSPHATASE AUTO-ANTIGENE DE 37 kD DU DIABETE SUCRE |
| US5670377A (en) * | 1996-03-14 | 1997-09-23 | Sansum Medical Research Foundation | Method of diagnosing gestational diabetes |
| AUPO468597A0 (en) | 1997-01-21 | 1997-02-13 | Montech Medical Developments Pty Ltd | Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase |
| US6303325B1 (en) | 1998-05-29 | 2001-10-16 | Dade Behring Inc. | Method for detecting analytes |
| DE19839736A1 (de) | 1998-09-01 | 2000-03-02 | Roche Diagnostics Gmbh | Humane monoklonale Antikörper gegen Inselzellantigen IA-2 |
| US20040048274A1 (en) | 2000-10-17 | 2004-03-11 | Morten Breindahl | Assay for directly detecting an inflammatory indicator in a body fluid sample |
| CA2443777A1 (fr) | 2001-04-10 | 2002-10-24 | The Board Of Trustees Of The Leland Stanford Junior University | Utilisation therapeutique et diagnostique de profils de specificite d'anticorps |
| US20050130245A1 (en) | 2001-09-17 | 2005-06-16 | Syn X Pharma, Inc. | Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins |
| US20040142387A1 (en) | 2002-05-29 | 2004-07-22 | University Of Washington | Mutants of GAD65 and Ian5 relating to diabetes |
| FR2847263B1 (fr) | 2002-11-18 | 2006-01-13 | Commissariat Energie Atomique | Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans |
| US9557325B2 (en) | 2003-06-09 | 2017-01-31 | Redox-Reactive Reagents Llc | Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| WO2004111608A2 (fr) | 2003-06-09 | 2004-12-23 | Mcintyre John A | Procede permettant de modifier la specificite de liaison des proteines plasmiques au moyen de reactions d'oxydation-reduction |
| EP1718327B1 (fr) | 2003-06-20 | 2015-01-07 | University of Florida | Biomarqueurs permettant de differencier des diabetes de types 1 et 2 |
| TW200508609A (en) | 2003-07-15 | 2005-03-01 | Bioarray Solutions Ltd | Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays |
| US7323346B2 (en) * | 2003-08-14 | 2008-01-29 | The General Hospital Corporation | Screening for gestational disorders |
| SE0400683D0 (sv) * | 2004-03-19 | 2004-03-19 | Forskarpatent I Syd Ab | Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis |
| US20060024725A1 (en) * | 2004-07-30 | 2006-02-02 | Robert Hussa | Oncofetal fibronectin as a marker for pregnancy-related indications |
| ITRM20050398A1 (it) | 2005-07-26 | 2007-01-27 | Gian Franco Bottazzo | Metodo per la rilevazione di cellule t in pazienti neodiagnosticati per diabete di tipo 1. |
| EP1942947A4 (fr) * | 2005-10-04 | 2010-09-01 | Res Foundation Of The State Un | Polypeptides de fibronectine et methodes d'utilisation |
| WO2007062789A1 (fr) * | 2005-11-29 | 2007-06-07 | F. Hoffmann-La Roche Ag | Fibronectine en tant que cible/marqueur pour l'insulinoresistance |
| EP1989554A1 (fr) | 2006-02-06 | 2008-11-12 | Rappaport Family Institute For Research in the Medical Sciences | Méthodes et trousse pour le diagnostic du diabète de type 1 |
| US20070224638A1 (en) | 2006-03-27 | 2007-09-27 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
| JP5694668B2 (ja) | 2006-12-29 | 2015-04-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ | 自己免疫疾患の診断上および治療上の標的ならびにその用途 |
| JP5636192B2 (ja) | 2007-02-21 | 2014-12-03 | エス・ア・エール・エル アンドセルＳａｒｌ Ｅｎｄｏｃｅｌｌｓ | 糖尿病の診断のためのヒト膵臓β細胞株 |
| WO2009033121A2 (fr) | 2007-09-06 | 2009-03-12 | University Of Washington | Molécules et procédés de traitement et de détection du diabète |
| WO2009045403A2 (fr) * | 2007-10-01 | 2009-04-09 | The Board Of Trustees Of The Leland Stanford Junior University | Régulation par la ménine de la prolifération des cellules d'îlots bêta |
| US20100017143A1 (en) * | 2008-01-30 | 2010-01-21 | Proteogenix, Inc. | Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health |
| WO2009097584A1 (fr) * | 2008-01-30 | 2009-08-06 | Proteogenix, Inc. | Biomarqueurs de sérum maternel pour la détection de pré-éclampsie |
| US9176120B2 (en) * | 2008-02-04 | 2015-11-03 | Women & Infants' Hospital Of Rhode Island | Serum-based, diagnostic, biological assay to predict pregnancy disorders |
| US8722343B2 (en) | 2008-11-21 | 2014-05-13 | Carla Perego | Methods and compositions for the diagnosis and treatment of diabetes |
| KR101067815B1 (ko) | 2009-02-05 | 2011-09-27 | 서울대학교산학협력단 | 제1형 당뇨병의 신규한 진단 마커 |
| US9939448B2 (en) | 2010-01-06 | 2018-04-10 | The Regents Of The University Of Colorado, A Body Corporate | Methods for detecting insulin autoantibody |
| US8748352B2 (en) | 2011-08-16 | 2014-06-10 | Battelle Memorial Institute | Peptide and protein biomarkers for type 1 diabetes mellitus |
-
2013
- 2013-03-11 EP EP13775210.1A patent/EP2836845B1/fr active Active
- 2013-03-11 IN IN9410DEN2014 patent/IN2014DN09410A/en unknown
- 2013-03-11 WO PCT/US2013/030152 patent/WO2013154709A1/fr active Application Filing
- 2013-03-11 CN CN201380031224.2A patent/CN104380112B/zh active Active
- 2013-03-11 US US13/792,844 patent/US8852873B2/en active Active
- 2013-03-11 ES ES13775210.1T patent/ES2684976T3/es active Active
- 2013-11-21 US US14/085,974 patent/US8975034B2/en active Active
-
2014
- 2014-10-16 US US14/516,383 patent/US9383370B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013154709A1 (fr) | 2013-10-17 |
| US20150037822A1 (en) | 2015-02-05 |
| US20140080157A1 (en) | 2014-03-20 |
| US9383370B2 (en) | 2016-07-05 |
| ES2684976T3 (es) | 2018-10-05 |
| EP2836845B1 (fr) | 2018-05-09 |
| EP2836845A1 (fr) | 2015-02-18 |
| US8975034B2 (en) | 2015-03-10 |
| EP2836845A4 (fr) | 2015-11-18 |
| CN104380112B (zh) | 2017-05-24 |
| CN104380112A (zh) | 2015-02-25 |
| US20130274123A1 (en) | 2013-10-17 |
| US8852873B2 (en) | 2014-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN09410A (fr) | ||
| WO2014144129A3 (fr) | Biomarqueurs et procédés de prédiction d'une naissance prématurée | |
| NZ707263A (en) | A test device and method for identifying pregnancy based on hcg and lh levels in a sample | |
| WO2009006323A3 (fr) | Procédés et combinaisons de marqueurs pour le dépistage d'une prédisposition à un cancer du poumon | |
| WO2014143977A3 (fr) | Biomarqueurs et procédés de prédiction de prééclampsie | |
| WO2013188686A3 (fr) | Biomarqueurs utilisés pour prédire ou détecter précocement la pré‑éclampsie et/ou le syndrome de hellp | |
| EP2772761A3 (fr) | Elément d'acide nucléique utilisable dans le cadre d'une analyse et procédé, réactif et instrument d'analyse l'utilisant | |
| SG10201906981TA (en) | Methods and reagents for the assessment of gestational diabetes | |
| IL302061B2 (en) | Prediction based on a model in a critically modeled filter bank | |
| WO2010087985A3 (fr) | Nouveaux marqueurs pour la détection de complications résultant de rencontres in utero | |
| WO2013036754A3 (fr) | Procédés et compositions pour le diagnostic d'un cancer ovarien | |
| WO2015031676A3 (fr) | Test d'intégrité d'échantillons de cheveux | |
| EP2569635A4 (fr) | Procédés de diagnostic et traitement de l'encéphalite ou de l'épilepsie | |
| MX2020010315A (es) | Ensayos sandwich de colocalizacion por enlace. | |
| MX369610B (es) | Metodos, dispositivos y sistemas para analisis de muestras. | |
| WO2008132753A3 (fr) | Procédés et trousses de détection de cellules fœtales dans le sang maternel | |
| WO2009111572A3 (fr) | Cellule, procédé et kit de réalisation d'un essai de neutralisation d'anticorps | |
| WO2013076579A3 (fr) | Procédés pour évaluer un risque de fracture osseuse | |
| WO2015086727A3 (fr) | Nouveau procédé de pronostic pour patients atteints d'un cancer | |
| NZ720608A (en) | Β-glucan assay methods | |
| WO2016198833A3 (fr) | Procédés | |
| WO2008132752A3 (fr) | Procédés et trousses de prédiction de métastases d'un cancer | |
| EP2998408A4 (fr) | Procédé d'obtention d'informations de cellule épi-génétique, procédé de détermination des caractéristiques cellulaires, procédé d'évaluation de la sensibilité à un médicament ou de sélection d'une variété de médicaments ou d'agents immunothérapeutiques, méthode de diagnostic de maladie, vecteur pouvant se répliquer, nécessaire de dosage et dispositif d'analyse | |
| WO2014198670A3 (fr) | Procédés de visualisation et d'analyse de données biologiques à contenu élevé | |
| EP3969915A4 (fr) | Réduction d'arrière-plan dans une analyse descendante des anticorps |